JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258163

Human RAD23A (hHR23A) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

RAD23A KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2 and 2 bp deletion in exon2.

View Alternative Names

HR23A, MGC111083, RAD 23a, RAD23 homolog A, RAD23 homolog A (S. cerevisiae), RAD23 yeast homolog A, RD23A_HUMAN, UV excision repair protein RAD23, UV excision repair protein RAD23 homolog A, hHR 23A

3 Images
Western blot - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)
  • WB

Unknown

Western blot - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)

Lane 1 : Wild-type HEK293T cell lysate (20 ug)
Lane 2 : RAD23A knockout HEK293T cell lysate (20 ug)
Lane 3 : MCF7 cell lysate (20 ug)
Lane 4 : Jurkat cell lysate (20 ug)

ab108591 was shown to specifically react with hHR23A in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266343 (knockout cell lysate ab258163) was used. Wild-type and hHR23A knockout samples were subjected to SDS-PAGE. ab108591 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4oC at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

false

Sanger Sequencing - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)
  • Sanger seq

Unknown

Sanger Sequencing - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)

Allele-2 : 1 bp deletion in exon2

Sanger Sequencing - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)
  • Sanger seq

Unknown

Sanger Sequencing - Human RAD23A (hHR23A) knockout HEK-293T cell lysate (AB258163)

Allele-1 : 2 bp deletion in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon2 and 2 bp deletion in exon2.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

style
left-column

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258163-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human RAD23A knockout HEK293T cell lysate", "number":"AB258163-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258163-CMP02", "productcode":"" } ] } } }
style
left-column

Properties and storage information

Gene name
RAD23A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The human homolog of Rad23A or hHR23A is an important player in protein maintenance and degradation pathways. This protein is known for its involvement in DNA repair mechanisms and proteasome function. hHR23A weighs approximately 43 kDa and expresses in many tissues reflecting its diverse roles throughout the body. Scientists also refer to it as RAD23A giving insight into its function by linking with the well-known RAD proteins.
Biological function summary

HHR23A contributes significantly to the protein ubiquitination process an essential cellular mechanism for targeting proteins for degradation. It forms part of a complex with ubiquitin aiding in the recognition and delivery of ubiquitinated proteins to the proteasome for degradation. The protein's ability to bind to both ubiquitin and the proteasome enables its dual function in proteolytic pathways positioning hHR23A as an intermediary that regulates protein turnover and stability.

Pathways

HHR23A engages in the ubiquitin-proteasome pathway and the nucleotide excision repair (NER) pathway. It cooperates with other proteins like Rad4 (XPC in humans) in NER where it functions in DNA damage recognition and repair. In the ubiquitin-proteasome pathway hHR23A interacts with the proteasomal subunit Rpn10 and other ubiquitin-like proteins. These interactions facilitate effective proteolysis of damaged or unnecessary proteins emphasizing its central role in controlling intracellular protein levels.

HHR23A has implications in neurodegenerative diseases and cancer. Impaired ubiquitin-proteasome system function involving hHR23A associates with neurodegenerative diseases such as Alzheimer's where protein aggregates accumulate. hHR23A's interaction with proteins like p53 known for its role in tumor suppression ties this protein to cancer biology highlighting its potential involvement in tumor suppression failure when its pathways are disrupted.
style
left-column

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

style
left-column

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Complementary Products

Proteins & Peptides

AB259412

Recombinant human VEGF 165A protein (Active)

Premium Bioactive

Mass Spectrometry - Recombinant human VEGF 165A protein (Active) (AB259412)

  • 0
  • 0
Primary Antibodies

AB108592

Anti-hHR23A antibody [EPR4818]

RabMAb|Recombinant

Western blot - Anti-hHR23A antibody [EPR4818] (AB108592)

  • 5
  • 3
Proteins & Peptides

AB180319

Recombinant Human RPL18A protein (denatured)

SDS-PAGE - Recombinant Human RPL18A protein (denatured) (AB180319)

  • 0
  • 0
Proteins & Peptides

AB288799

Recombinant Human VCAM1 protein (Active)

Premium Bioactive

Biological Activity - Recombinant Human VCAM1 protein (Active) (AB288799)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com